Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank

<p><strong>Background:</strong><br /> Although prostate cancer is a leading cause of cancer death, its aetiology is not well understood. We aimed to identify novel biochemical factors for prostate cancer incidence and mortality in UK Biobank.</p><br /> <p>&...

Full description

Bibliographic Details
Main Authors: Perez-Cornago, A, Fensom, GK, Andrews, C, Watts, EL, Allen, NE, Martin, RM, Van Hemelrijck, M, Key, TJ, Travis, RC
Format: Journal article
Language:English
Published: Springer Nature 2020
_version_ 1797069013124120576
author Perez-Cornago, A
Fensom, GK
Andrews, C
Watts, EL
Allen, NE
Martin, RM
Van Hemelrijck, M
Key, TJ
Travis, RC
author_facet Perez-Cornago, A
Fensom, GK
Andrews, C
Watts, EL
Allen, NE
Martin, RM
Van Hemelrijck, M
Key, TJ
Travis, RC
author_sort Perez-Cornago, A
collection OXFORD
description <p><strong>Background:</strong><br /> Although prostate cancer is a leading cause of cancer death, its aetiology is not well understood. We aimed to identify novel biochemical factors for prostate cancer incidence and mortality in UK Biobank.</p><br /> <p><strong>Methods:</strong><br /> A range of cardiovascular, bone, joint, diabetes, renal and liver-related biomarkers were measured in baseline blood samples collected from up to 211,754 men at recruitment and in a subsample 5 years later. Participants were followed-up via linkage to health administrative datasets to identify prostate cancer cases. Hazard ratios (HRs) and 95% confidence intervals were calculated using multivariable-adjusted Cox regression corrected for regression dilution bias. Multiple testing was accounted for by using a false discovery rate controlling procedure.</p><br /> <p><strong>Results:</strong><br /> After an average follow-up of 6.9 years, 5763 prostate cancer cases and 331 prostate cancer deaths were ascertained. Prostate cancer incidence was positively associated with circulating vitamin D, urea and phosphate concentrations and inversely associated with glucose, total protein and aspartate aminotransferase. Phosphate and cystatin-C were the only biomarkers positively and inversely, respectively, associated with risk in analyses excluding the first 4 years of follow-up. There was little evidence of associations with prostate cancer death.</p><br /> <p><strong>Conclusion:</strong><br /> We found novel associations of several biomarkers with prostate cancer incidence. Future research will examine associations by tumour characteristics.</p>
first_indexed 2024-03-06T22:18:19Z
format Journal article
id oxford-uuid:542c34c7-4905-4a63-a17e-abc7aa877cae
institution University of Oxford
language English
last_indexed 2024-03-06T22:18:19Z
publishDate 2020
publisher Springer Nature
record_format dspace
spelling oxford-uuid:542c34c7-4905-4a63-a17e-abc7aa877cae2022-03-26T16:36:09ZExamination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK BiobankJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:542c34c7-4905-4a63-a17e-abc7aa877caeEnglishSymplectic ElementsSpringer Nature2020Perez-Cornago, AFensom, GKAndrews, CWatts, ELAllen, NEMartin, RMVan Hemelrijck, MKey, TJTravis, RC<p><strong>Background:</strong><br /> Although prostate cancer is a leading cause of cancer death, its aetiology is not well understood. We aimed to identify novel biochemical factors for prostate cancer incidence and mortality in UK Biobank.</p><br /> <p><strong>Methods:</strong><br /> A range of cardiovascular, bone, joint, diabetes, renal and liver-related biomarkers were measured in baseline blood samples collected from up to 211,754 men at recruitment and in a subsample 5 years later. Participants were followed-up via linkage to health administrative datasets to identify prostate cancer cases. Hazard ratios (HRs) and 95% confidence intervals were calculated using multivariable-adjusted Cox regression corrected for regression dilution bias. Multiple testing was accounted for by using a false discovery rate controlling procedure.</p><br /> <p><strong>Results:</strong><br /> After an average follow-up of 6.9 years, 5763 prostate cancer cases and 331 prostate cancer deaths were ascertained. Prostate cancer incidence was positively associated with circulating vitamin D, urea and phosphate concentrations and inversely associated with glucose, total protein and aspartate aminotransferase. Phosphate and cystatin-C were the only biomarkers positively and inversely, respectively, associated with risk in analyses excluding the first 4 years of follow-up. There was little evidence of associations with prostate cancer death.</p><br /> <p><strong>Conclusion:</strong><br /> We found novel associations of several biomarkers with prostate cancer incidence. Future research will examine associations by tumour characteristics.</p>
spellingShingle Perez-Cornago, A
Fensom, GK
Andrews, C
Watts, EL
Allen, NE
Martin, RM
Van Hemelrijck, M
Key, TJ
Travis, RC
Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
title Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
title_full Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
title_fullStr Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
title_full_unstemmed Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
title_short Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank
title_sort examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in uk biobank
work_keys_str_mv AT perezcornagoa examinationofpotentialnovelbiochemicalfactorsinrelationtoprostatecancerincidenceandmortalityinukbiobank
AT fensomgk examinationofpotentialnovelbiochemicalfactorsinrelationtoprostatecancerincidenceandmortalityinukbiobank
AT andrewsc examinationofpotentialnovelbiochemicalfactorsinrelationtoprostatecancerincidenceandmortalityinukbiobank
AT wattsel examinationofpotentialnovelbiochemicalfactorsinrelationtoprostatecancerincidenceandmortalityinukbiobank
AT allenne examinationofpotentialnovelbiochemicalfactorsinrelationtoprostatecancerincidenceandmortalityinukbiobank
AT martinrm examinationofpotentialnovelbiochemicalfactorsinrelationtoprostatecancerincidenceandmortalityinukbiobank
AT vanhemelrijckm examinationofpotentialnovelbiochemicalfactorsinrelationtoprostatecancerincidenceandmortalityinukbiobank
AT keytj examinationofpotentialnovelbiochemicalfactorsinrelationtoprostatecancerincidenceandmortalityinukbiobank
AT travisrc examinationofpotentialnovelbiochemicalfactorsinrelationtoprostatecancerincidenceandmortalityinukbiobank